Memorial Day Sale!

Our subscribers are smart and they want to make good financial decisions.

To generate wealth, investors have been subscribing to the paid services of The Arora Report in large numbers.  Those who made the decision to subscribe to the paid services have done remarkably well  due to the guidance and information they received.

The Arora Report gives investors multiple edges they cannot get anywhere else.  With the help of The Arora Report they have beaten the market and they intend on doing so for a long time.  With The Arora Report a knowledgeable investor could have turned $100,000 into over $1,500,000. Of course, no one knows the future and past performance is not a guarantee of future performance.

Our subscribers have made a fortune from our remarkable success in identifying companies that get bought out.  To date 165 of our portfolio companies have been bought out.

Free Trials

Memorial Day is a good time to take advantage of the 30 day free trials.  Your credit card is not charged during the first 30 days.  You can cancel within 30 days and owe  nothing.

Please click here to take a free trial.

First Bonus – Billionaire Techniques

When you subscribe, you get access to Trade Management Guidelines. These are the techniques used by billionaires and hedge funds.  You can learn and continue to use these techniques even if you decide to cancel.

Second Bonus – Save $2,005

It is a fact that the more knowledge you have, the more money you make in the markets. For those taking the Free trial now, you get $2005 off the widely acclaimed seminar Bullet Proof Your Portfolio and Increase Your Returns.

Coronavirus Recovery

The Arora Report correctly called the risk of coronavirus on January 23, 2020 right before the big drop in the market giving investors plenty of time to protect their portfolios.  In March, many stocks and ETFs pulled back to the Arora Buy Zones giving investors opportunities to buy stocks at great prices. Investors who bought generated great gains in a short time. Early on after the drop, The Arora Report correctly called that the stock market would make new highs -at that time. The Arora Report was the only one making this bold prediction which has turned out to be true.

The Coronavirus Recovery Portfolio of The Arora Report has done very well.

What To Do Now

Every morning we update you on what to do now:

  • How much cash to hold.
  • How much in  hedges to hold.
  • What to do with long term positions.

Short Term Trades

In addition to long term investments, with ZYX Buy and ZYX Short you get plenty of short term trades.  Our record is unmatched. The secret behind the unmatched record is that we do not force setups unlike most other services.

Completely Objective and Independent

The Arora Report is a rare publisher that does not accept advertisements.  The Arora Report has forsaken a very large sum of money by not accepting advertisements, payments by companies and payments by the brokers. This way The Arora Report is dedicated solely to the investors, investment advisors and money managers.

Free Trials

If you want only one service, pick between ZYX Buy and ZYX Allocation.

Pick ZYX Buy if you like individual stocks, buyouts, long term investments and short term trades.

Pick ZYX Allocation if you like ETFs, want to focus on medium to long term and do not want to be very active.

Please click here to take a free trial.

Very Popular

Our Corporate Bundle is very popular as it provides you with the most opportunities and lowers your risk.  You also get all four services for the price of two.

Please click here to take a free trial.

A knowledgeable investor could have turned $100,000 into over $1,000,000 with the help from The Arora Report. NOW YOU TOO CAN ALSO SPECTACULARLY SUCCEED AT MEETING YOUR GOALS WITH THE HELP OF THE ARORA REPORT. You are receiving less than 2% of the content from our paid services. …TO RECEIVE REMAINING 98% INCLUDING MANY ATTRACTIVE INVESTMENT OPPORTUNITIES, TAKE A FREE TRIAL TO PAID SERVICES.

Please click here to take advantage of a FREE  30 day trial.